Omecrit-40
Omeprazole 40 mg Injection
Rapid Acid Suppression for Critical Gastric Protection
Omeprazole 40 mg Injection is a proton pump inhibitor (PPI) designed for fast, effective control of gastric acid secretion in hospitalized patients. It offers a convenient and reliable solution for managing acid-related disorders when oral administration is not possible, making it ideal for ICU, surgical, and emergency care.
Key Benefits:
Fast-Acting Acid Suppression:
Quickly inhibits gastric acid secretion by irreversibly blocking the H⁺/K⁺ ATPase enzyme in parietal cells.
IV Advantage for Acute Situations:
Suitable for patients who are NPO (nothing by mouth), post-operative, or critically ill.
Effective Gastric Protection:
Prevents stress-related mucosal damage and gastrointestinal bleeding in high-risk hospitalized patients.
Clinically Proven Efficacy:
Widely used in the treatment and prevention of peptic ulcers, erosive esophagitis, and upper GI bleeding.
Indications:
Stress ulcer prophylaxis in critically ill patients
Gastroesophageal reflux disease (GERD) with complications
Peptic ulcer disease
Zollinger-Ellison syndrome
Upper gastrointestinal bleeding
As pre-anesthetic medication to reduce gastric acidity
Dosage & Administration:
Administered as an intravenous injection or infusion. Typical dose: 40 mg once daily or as directed by the physician, based on severity and clinical condition.
Important Safety Information:
Generally well-tolerated. Prolonged use may lead to vitamin B12 deficiency, hypomagnesemia, or increased risk of infections. Use with caution in patients with hepatic impairment.
Brand Name | Omecrit 40 |
---|---|
Composition | Omeprazole 40MG |
MRP | ₹220 |
Packing | 10ML Vial+WFI |